- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02811432
Kangaroo Mother Care Before Stabilisation Amongst Low Birth Weight Neonates in Africa (OMWaNA)
The OMWaNA Study: Operationalising Kangaroo Mother Care Before Stabilisation Amongst Low Birth Weight Neonates in Africa: a Multi-site Randomised Controlled Trial to Examine Mortality Impact in Uganda
Study Overview
Status
Intervention / Treatment
Detailed Description
METHODS Study setting, design, and participants The OMWaNA trial was an individually randomised, controlled, superiority trial with two parallel arms allocated in a 1:1 ratio to receive KMC initiated before stabilisation (intervention) or standard care (control). The trial was conducted in the neonatal units (WHO level-2) of five government hospitals in Uganda (appendix p 5). Infrastructure and equipment improvements as well as training were required prior to trial initiation, as described previously.10 All hospitals were provided with essential equipment and supplies to support the provision of KMC and level-2 newborn care. Details regarding study context and methods have been published in the trial protocol9 and are briefly summarised here. Ugandan practice is that maternity and newborn care should be provided free of charge in government health facilities;11 however, families are expected to support caregivers to meet essential needs such as meals.
The trial is reported here in accordance with the CONSORT guidelines. All live-born neonates, aged 1 to <48 hours and weighing 700-2000g, who were admitted to participating hospitals and for whom the indication for KMC was "uncertain" according to WHO guidance concerning clinical stability, defined as receiving ≥1 therapy (oxygen, continuous positive airway pressure [CPAP] where available, intravenous [IV] fluids, therapeutic antibiotics, anti-seizure medication), were eligible for inclusion. Exclusion criteria included triplet or higher multi-fetal pregnancy (unless pregnancy resulted in demise of ≥1 fetus) and parent/caregiver being unable/unwilling to provide either consent, KMC, and/or attend follow-up visits. Neonates with life-threatening instability, severe jaundice requiring immediate management, active seizures, or major congenital malformations were also excluded. The study was approved by the Research Ethics Committees of Uganda Virus Research Institute (GC/127/19/06/717), Uganda National Council of Science and Technology (HS 2645), and London School of Hygiene & Tropical Medicine (LSHTM, 16972). The trial was overseen by a steering committee and an independent data and safety monitoring board (DSMB).
Screening and informed consent All admitted neonates weighing ≤2000g were screened for eligibility by study staff. Stable neonates (meeting WHO 2019 criteria for KMC eligibility) were excluded and remaining neonates were assessed for eligibility. Those who met criteria for 'life-threatening instability' or who had conditions precluding KMC (e.g., seizures, jaundice), were reassessed every 3 hours up to 48 hours, after which they were excluded. Written informed parental consent was obtained for all participants.
Randomisation, allocation concealment and masking A random allocation sequence was computer-generated using permuted blocks of varying sizes stratified by birthweight (<1000g, 1000-1499g, ≥1500g) and recruitment site. Allocation concealment was done by programming the allocation sequence into the screening database and revealing treatment group only when screening of eligible neonates was complete. Neonates from multiple births (twins or triplets) were allocated to the same arm according to first-born allocation.14 Masking of parents, caregivers, or healthcare workers was not possible due to the nature of the KMC intervention.
Procedures In the intervention arm, KMC was initiated soon after randomisation. Neonates were naked except for hat and diaper, placed prone and skin-to-skin on caregiver's chest, and secured using a KMC wrap. Adjustable beds were provided to facilitate continuous skin-to-skin care. KMC duration was charted by caregivers and verified by study staff. When not in KMC (e.g., during maternal bathing), incubator or radiant heater care was commenced. Study personnel, in addition to hospital staff, provided continuous KMC counselling throughout the hospitalisation. Control arm neonates were cared for in an incubator or radiant heater, as per hospital practice. Caregivers could have physical contact with their newborn but skin-to-skin contact was not initiated until stability criteria were met.9 Once stable, newborns were transferred to routine (intermittent) KMC. Neonates in both arms received standard clinical care according to hospital guidelines.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Ruth Canter, MSc
- Phone Number: +44 (0)20 7927 2071
- Email: ruth.canter@lshtm.ac.uk
Study Contact Backup
- Name: Melissa Medvedev (Morgan), MD, MSc
- Email: melissa.morgan@lshtm.ac.uk
Study Locations
-
-
-
Entebbe, Uganda
- Entebbe
-
Iganga, Uganda
- Iganga District Hospital
-
Jinja, Uganda
- Jinja Regional Referral Hospital
-
Masaka, Uganda
- Masaka Regional Referral Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion criteria
- Liveborn at Jinja Hospital, Masaka Hospital, Entebbe Hospital, or Iganga Hospital
- Singleton or twin pregnancy
- Birthweight ≥700g and ≤2000g
- Chronological age 1-48 hours at time of screening
- Alive at time of recruitment
- Parent/caregiver able and willing to provide KMC
- Parent/caregiver willing to attend follow-up visit
- Indication for KMC "uncertain" according to WHO guideline concerning clinical stability: pragmatically defined as receiving ≥1 therapy: oxygen, CPAP, IV fluids, therapeutic antibiotics, phenobarbital
Exclusion criteria
- Outborn
- Result of triplet or higher order multifetal pregnancy
- Indication for KMC "certain" according to WHO guidelines: pragmatically defined as clinically well neonates receiving none of the above therapy-based criteria
Severely life-threatening instability defined as SpO2 <88% in oxygen AND ≥1 of:
- Respiratory rate <20 or >100 breaths/min
- Apnoea requiring bag-mask ventilation
- HR <100 or >200 bpm
- Severe jaundice requiring immediate management
- Active neonatal seizures
- Major congenital malformation
- Parent does not provide written informed consent to participate in trial
- Mother or neonate enrolled in another MRC/UVRI research project
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Kangaroo mother care
Skin-to-skin care initiated as soon as possible following randomisation
|
Skin-to-skin care (target: at least 18 hours per day)
Other Names:
|
Active Comparator: Standard care
Incubator or radiant warmer
|
Incubator or radiant warmer until neonate meets stability criteria; once stable (WHO indication for KMC certain), the baby can transition to routine (intermittent) KMC
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Mortality within 7 days
Time Frame: 7 days
|
7 days
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Prevalence of hypothermia at 24 hours post-randomisation
Time Frame: 24 hours
|
24 hours
|
Time from intervention/control procedures starting to clinical stabilisation
Time Frame: 30 days
|
30 days
|
Time from intervention/control procedures starting to death
Time Frame: 30 days
|
30 days
|
Proportion of neonates exclusively breastmilk feeding at discharge
Time Frame: 30 days
|
30 days
|
Mortality within 28 days
Time Frame: 28 days
|
28 days
|
Frequency of readmission
Time Frame: 30 days
|
30 days
|
Daily weight gain at 28 days
Time Frame: 28 days
|
28 days
|
Infant-caregiver attachment at 28 days
Time Frame: 28 days
|
28 days
|
Women's well-being at 28 days
Time Frame: 28 days
|
28 days
|
Mean duration of hospital stay in days
Time Frame: 30 days
|
30 days
|
Collaborators and Investigators
Publications and helpful links
General Publications
- Medvedev MM, Tumukunde V, Mambule I, Tann CJ, Waiswa P, Canter RR, Hansen CH, Ekirapa-Kiracho E, Katumba K, Pitt C, Greco G, Brotherton H, Elbourne D, Seeley J, Nyirenda M, Allen E, Lawn JE. Operationalising kangaroo Mother care before stabilisation amongst low birth Weight Neonates in Africa (OMWaNA): protocol for a randomised controlled trial to examine mortality impact in Uganda. Trials. 2020 Jan 31;21(1):126. doi: 10.1186/s13063-019-4044-6.
- Medvedev MM, Tumukunde V, Kirabo-Nagemi C, Greco G, Mambule I, Katumba K, Waiswa P, Tann CJ, Elbourne D, Allen E, Ekirapa-Kiracho E, Pitt C, Lawn JE. Process and costs for readiness to safely implement immediate kangaroo mother care: a mixed methods evaluation from the OMWaNA trial at five hospitals in Uganda. BMC Health Serv Res. 2023 Jun 10;23(1):613. doi: 10.1186/s12913-023-09624-z.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Institute of Psychiatry
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
- ANALYTIC_CODE
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Preterm Infant
-
Duke UniversityNational Institute of Nursing Research (NINR)CompletedPreterm Infant Development | Preterm Infant Health
-
Christiana Care Health ServicesCompletedInfant | Infant, Premature | Infant, Preterm | Infant, LateUnited States
-
Medical University of GrazCompleted
-
NICHD Neonatal Research NetworkEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedInfant, Newborn | Infant, Moderate PretermUnited States
-
NICHD Neonatal Research NetworkEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedInfant, Newborn | Infant, Moderate PretermUnited States
-
University of OxfordShoklo Malaria Research UnitCompleted
-
yangjieCompletedOutcome, Fatal | Preterm Infant | Morbidity;Infant
-
Medical University of GrazCompletedIntubation; Difficult or Failed | Preterm Infant | Term InfantAustria
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaCompletedPreterm Birth | Cerebral Autoregulation | Premature Infant DiseaseItaly
-
Nantes University HospitalCompleted
Clinical Trials on Kangaroo mother care
-
University of the PhilippinesPfizerCompletedLow Birth Weight Among NeonatesPhilippines
-
University of Alabama at BirminghamCompleted
-
Society for Applied StudiesCentre For International HealthCompleted
-
Saglik Bilimleri UniversitesiRecruitingPremature Infant | Mother-Infant Interaction | Fathers | Kangaroo CareTurkey
-
Rajiv BahlEmory University; Hawassa University; Mekelle University; Emory University EthiopiaCompleted
-
Addis Ababa UniversityWorld Health Organization; Harvard School of Public Health (HSPH)CompletedLow Birth-weightEthiopia
-
IWK Health CentreCanadian Institutes of Health Research (CIHR); Nova Scotia Health Research... and other collaboratorsCompleted
-
Fatih UniversityUnknownImmaturity | Oral Intolerance | Postnatal AdaptationTurkey
-
University of South CarolinaGhana Health Services; Korle-Bu Teaching Hospital, Accra, Ghana; Centre for Learning...Not yet recruiting